Profil
Eric Forquenot de la Fortelle is currently Chief Executive Officer at Health Opportunities GmbH.
He is an Independent Director at Sensorion SA since 2015, Director at Mint Solutions Holding BV since 2014, Director at Vertero Therapeutics, Inc. since 2019, Director at DayTwo Ltd. since 2017, Director at Dermala, Inc. since 2020, Director at LiMM Therapeutics SA since 2018, Director at Ganymed Robotics SAS, and Managing Partner at Cathay Capital Private Equity SAS since 2021.
Former roles include Chief Executive Officer at Cell Medica Switzerland AG, Non-Executive Director at Maat Pharma SA from 2014 to 2020, Director at TargEDys SA, Director at BiomX Ltd., Director at Siolta Therapeutics, Inc., Principal at F.
Hoffmann-La Roche Ltd. from 2005 to 2013, and Venture Partner at Seventure Partners SA from 2014 to 2021.
Education includes an MBA from INSEAD, a doctorate from Université de Paris XI Paris Sud, and an undergraduate degree from École Centrale Paris.
Postes actifs de Eric Forquenot de la Fortelle
| Sociétés | Poste | Début |
|---|---|---|
| SENSORION | Directeur/Membre du Conseil | 09/03/2015 |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital PE invests in small and middle market companies located across the globe primarily in North America, Europe and Asia. The firm targets companies operating in the fields of healthcare, consumer, technology, business transformation & software and financial industries. It provides financing for growth rounds to leveraged buy-outs. The firm acquires majority or minority interests. It acts as a lead investor. | Private Equity Investor | 01/09/2021 |
Dermala, Inc.
Dermala, Inc. Household/Personal CareConsumer Non-Durables Develops and manufactures skin care products and sells through online store | Directeur/Membre du Conseil | 01/11/2020 |
DayTwo Ltd.
DayTwo Ltd. Medical/Nursing ServicesHealth Services Provides personalized nutrition and actionable insights that allows to live healthier and maintain normal blood sugar levels | Directeur/Membre du Conseil | 01/05/2017 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Directeur/Membre du Conseil | 01/03/2019 |
Health Opportunities GmbH | Directeur Général | - |
Mint Solutions Holding BV
Mint Solutions Holding BV Medical SpecialtiesHealth Technology Develops and manufactures medication safety system | Directeur/Membre du Conseil | 01/07/2014 |
Ganymed Robotics SAS
Ganymed Robotics SAS Industrial MachineryProducer Manufacturing Develops robots for orthopaedic surgery | Directeur/Membre du Conseil | - |
Anciens postes connus de Eric Forquenot de la Fortelle
| Sociétés | Poste | Fin |
|---|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Corporate Officer/Principal | 01/09/2021 |
| ░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Eric Forquenot de la Fortelle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Centrale Paris
École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital PE invests in small and middle market companies located across the globe primarily in North America, Europe and Asia. The firm targets companies operating in the fields of healthcare, consumer, technology, business transformation & software and financial industries. It provides financing for growth rounds to leveraged buy-outs. The firm acquires majority or minority interests. It acts as a lead investor. | Finance |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Health Technology |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Mint Solutions Holding BV
Mint Solutions Holding BV Medical SpecialtiesHealth Technology Develops and manufactures medication safety system | Health Technology |
Maat Pharma SA
Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology Develops and manufactures nutritional solutions to control metabolic diseases | Health Technology |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
DayTwo Ltd.
DayTwo Ltd. Medical/Nursing ServicesHealth Services Provides personalized nutrition and actionable insights that allows to live healthier and maintain normal blood sugar levels | Health Services |
Health Opportunities GmbH | |
Dermala, Inc.
Dermala, Inc. Household/Personal CareConsumer Non-Durables Develops and manufactures skin care products and sells through online store | Consumer Non-Durables |
Siolta Therapeutics, Inc.
Siolta Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic microbial consortia to prevent and treat inflammatory diseases | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Ganymed Robotics SAS
Ganymed Robotics SAS Industrial MachineryProducer Manufacturing Develops robots for orthopaedic surgery | Producer Manufacturing |
















